Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipocyte | 7 studies | 23% ± 4% | |
endothelial cell | 6 studies | 27% ± 9% | |
GABAergic neuron | 5 studies | 35% ± 16% | |
astrocyte | 5 studies | 25% ± 8% | |
microglial cell | 5 studies | 21% ± 5% | |
macrophage | 5 studies | 26% ± 9% | |
glutamatergic neuron | 4 studies | 49% ± 18% | |
interneuron | 4 studies | 35% ± 20% | |
oligodendrocyte precursor cell | 3 studies | 30% ± 8% | |
transit amplifying cell | 3 studies | 34% ± 21% | |
oligodendrocyte | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 37% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2696.25 | 1445 / 1445 | 100% | 30.81 | 183 / 183 |
bladder | 100% | 2750.62 | 21 / 21 | 100% | 21.03 | 503 / 504 |
uterus | 100% | 3966.54 | 170 / 170 | 100% | 26.92 | 458 / 459 |
lung | 100% | 3761.97 | 578 / 578 | 100% | 24.92 | 1151 / 1155 |
ovary | 100% | 3974.95 | 180 / 180 | 100% | 17.67 | 428 / 430 |
intestine | 100% | 3013.55 | 966 / 966 | 99% | 16.88 | 524 / 527 |
prostate | 100% | 3291.68 | 245 / 245 | 99% | 13.61 | 499 / 502 |
breast | 100% | 3353.20 | 459 / 459 | 99% | 20.40 | 1111 / 1118 |
stomach | 100% | 2222.60 | 359 / 359 | 99% | 17.95 | 284 / 286 |
thymus | 100% | 3213.80 | 653 / 653 | 99% | 15.19 | 600 / 605 |
pancreas | 100% | 1537.16 | 328 / 328 | 99% | 17.38 | 176 / 178 |
brain | 98% | 2143.08 | 2594 / 2642 | 100% | 17.92 | 704 / 705 |
skin | 100% | 3680.52 | 1809 / 1809 | 97% | 15.44 | 458 / 472 |
adrenal gland | 100% | 2165.64 | 258 / 258 | 96% | 13.48 | 220 / 230 |
liver | 100% | 2901.27 | 226 / 226 | 95% | 11.26 | 387 / 406 |
kidney | 100% | 2280.93 | 89 / 89 | 95% | 14.14 | 857 / 901 |
adipose | 100% | 3640.73 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.58 | 29 / 29 |
spleen | 100% | 3858.81 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.05 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.65 | 1 / 1 |
blood vessel | 100% | 3187.44 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1529.12 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1495.54 | 853 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 7.91 | 68 / 80 |
peripheral blood | 74% | 1707.00 | 684 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1905870 | Biological process | positive regulation of 3'-UTR-mediated mRNA stabilization |
GO_0007062 | Biological process | sister chromatid cohesion |
GO_0006397 | Biological process | mRNA processing |
GO_0071076 | Biological process | RNA 3' uridylation |
GO_0006302 | Biological process | double-strand break repair |
GO_0060212 | Biological process | negative regulation of nuclear-transcribed mRNA poly(A) tail shortening |
GO_0007076 | Biological process | mitotic chromosome condensation |
GO_0043634 | Biological process | polyadenylation-dependent ncRNA catabolic process |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0031123 | Biological process | RNA 3'-end processing |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0031499 | Cellular component | TRAMP complex |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005634 | Cellular component | nucleus |
GO_0070568 | Molecular function | guanylyltransferase activity |
GO_1990817 | Molecular function | poly(A) RNA polymerase activity |
GO_0043221 | Molecular function | SMC family protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | TENT4A |
Protein name | Terminal nucleotidyltransferase 4A Terminal nucleotidyltransferase 4A (DNA polymerase sigma) (LAK-1) (Non-canonical poly(A) RNA polymerase PAPD7) (EC 2.7.7.19) (PAP-associated domain-containing protein 7) (TRAMP-like complex polyadenylate polymerase) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 5) (TUTase 5) (Topoisomerase-related function protein 4-1) (TRF4-1) |
Synonyms | TRF4 POLS PAPD7 |
Description | FUNCTION: Terminal nucleotidyltransferase that catalyzes preferentially the transfer of ATP and GTP on RNA 3' poly(A) tail creating a heterogeneous 3' poly(A) tail leading to mRNAs stabilization by protecting mRNAs from active deadenylation . Also functions as a catalytic subunit of a TRAMP-like complex which has a poly(A) RNA polymerase activity and is involved in a post-transcriptional quality control mechanism. Polyadenylation with short oligo(A) tails is required for the degradative activity of the exosome on several of its nuclear RNA substrates. Has no terminal uridylyltransferase activity, and does not play a role in replication-dependent histone mRNA degradation via uridylation . . |
Accessions | A0A9H4DBI9 Q5XG87 ENST00000631941.2 ENST00000515721.1 ENST00000230859.8 [Q5XG87-1] D6RJD0 |